当前位置:首页 - 行情中心 - 创新医疗(002173) - 财务分析 - 现金流量表

创新医疗

(002173)

  

流通市值:91.88亿  总市值:97.39亿
流通股本:4.16亿   总股本:4.41亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金638,403,885.18457,490,748.45190,074,749.28792,934,468.01
  收到的税费返还---1,050,627.06
  收到其他与经营活动有关的现金4,910,503.523,536,368.681,698,282.6110,221,024.02
  经营活动现金流入小计643,314,388.7461,027,117.13191,773,031.89804,206,119.09
  购买商品、接受劳务支付的现金259,267,653.79163,250,051.6971,941,326.83385,092,537.05
  支付给职工以及为职工支付的现金263,178,301.43178,740,188.1495,110,635.68344,639,582.17
  支付的各项税费13,167,251.111,311,455.138,369,085.9714,129,025.12
  支付其他与经营活动有关的现金35,976,974.8524,003,137.7611,610,936.1267,689,254.4
  经营活动现金流出小计571,590,181.17377,304,832.72187,031,984.6811,550,398.74
  经营活动产生的现金流量净额71,724,207.5383,722,284.414,741,047.29-7,344,279.65
二、投资活动产生的现金流量:
  收回投资收到的现金76,776,006.2676,776,006.2655,025,416.67423,794,726.72
  取得投资收益收到的现金--0.07393,973.87
  处置固定资产、无形资产和其他长期资产收回的现金净额90,625.6686,725.66-75,939.58
  处置子公司及其他营业单位收到的现金净额---3,881,959.35
  收到的其他与投资活动有关的现金---300,000
  投资活动现金流入小计76,866,631.9276,862,731.9255,025,416.74428,446,599.52
  购建固定资产、无形资产和其他长期资产支付的现金52,757,041.6546,984,270.3733,966,914.246,954,729.54
  投资支付的现金---511,112,319.83
  取得子公司及其他营业单位支付的现金1,066,405.35---
  支付其他与投资活动有关的现金---300,000
  投资活动现金流出小计53,823,44746,984,270.3733,966,914.2558,367,049.37
  投资活动产生的现金流量净额23,043,184.9229,878,461.5521,058,502.54-129,920,449.85
三、筹资活动产生的现金流量:
  取得借款收到的现金18,000,00018,000,00010,000,00049,000,000
  收到其他与筹资活动有关的现金351,000321,000321,0004,914,000
  筹资活动现金流入小计18,351,00018,321,00010,321,00053,914,000
  偿还债务支付的现金15,800,00013,000,0005,000,00030,000,000
  分配股利、利润或偿付利息支付的现金2,029,613.521,340,533.97652,617.952,591,332.78
  支付其他与筹资活动有关的现金9,965,776.36,059,298.14,181,657.1515,574,139.29
  筹资活动现金流出小计27,795,389.8220,399,832.079,834,275.148,165,472.07
  筹资活动产生的现金流量净额-9,444,389.82-2,078,832.07486,724.95,748,527.93
五、现金及现金等价物净增加额85,323,002.63111,521,913.8926,286,274.73-131,516,201.57
  加:期初现金及现金等价物余额117,503,433.44117,503,433.44117,503,433.44249,019,635.01
  期末现金及现金等价物余额202,826,436.07229,025,347.33143,789,708.17117,503,433.44
补充资料:
  净利润--11,191,930.35--93,988,272.5
  资产减值准备--3,420,710.72-2,654,963.89
  固定资产和投资性房地产折旧-39,086,122.39-84,730,702.68
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-39,086,122.39-84,730,702.68
  无形资产摊销-3,529,955.05-7,570,149.18
  长期待摊费用摊销-3,552,967.64-6,635,042.92
  处置固定资产、无形资产和其他长期资产的损失--13,836.71-1,422,556.57
  固定资产报废损失-1,502,696.5-3,392,082.83
  公允价值变动损失--2,734,231.68--6,328,693.68
  财务费用-1,891,980.62-4,090,769.8
  投资损失-2,595,176.56-4,348,134.7
  递延所得税-149,917.17--8,250,311.28
  其中:递延所得税资产减少-521,227.69--7,795,764.71
    递延所得税负债增加--371,310.52--454,546.57
  存货的减少-12,257,838.84--470,765.9
  经营性应收项目的减少-53,099,268.39--27,789,116.67
  经营性应付项目的增加--17,870,415.48--1,539,974.19
  其他--3,195,894.78-6,543,553.3
  融资租入固定资产---947,121.57
  现金的期末余额-229,025,347.33-117,503,433.44
  减:现金的期初余额-117,503,433.44-249,019,635.01
  现金及现金等价物的净增加额-111,521,913.89--131,516,201.57
公告日期2025-10-252025-08-092025-04-282025-04-12
审计意见(境内)标准无保留意见
TOP↑